Patents by Inventor Peter Kremminger

Peter Kremminger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hemoregulatory compounds
    Patent number: 6197793
    Abstract: Novel compounds of general formula (I) which have homoregulatory activities and can be used to stimulate haematopoiesis and for the treatment of viral, fungal and bacterial infectious diseases.
    Type: Grant
    Filed: December 4, 1998
    Date of Patent: March 6, 2001
    Assignees: SmithKline Beecham Corporation, Nycomed Austria GmbH
    Inventors: Pradip Kumar Bhatnagar, Michael Hartmann, Johann Hiebl, Peter Kremminger, Franz Rovenszky
  • Hemoregulatory compounds
    Patent number: 6191146
    Abstract: The present invention relates to novel compounds which have hemoregulatory activities and can be used to stimulate hematopoiesis and for the treatment of viral, fungal and bacterial infectious diseases.
    Type: Grant
    Filed: April 1, 1999
    Date of Patent: February 20, 2001
    Assignees: SmithKline Beecham Corporation, Nycomed Austria GmbH
    Inventors: Pradip Kumar Bhatnagar, Dirk Andries Heerding, James Francis Callahan, Michael Hartmann, Johann Hiebl, Peter Kremminger, Franz Rovenszky
  • Morphine derivatives with analgesic activity
    Patent number: 6150524
    Abstract: Morphine derivatives of formula (I), process for perparing them and their use and use as analgesics.
    Type: Grant
    Filed: December 8, 1998
    Date of Patent: November 21, 2000
    Assignee: CeNeS Ltd.
    Inventors: Michael Hartmann, Dagmar Stimmeder, Steinar Engelsen, Andreas Koch, Franz Rovenszky, Peter Kremminger, Michael Hutzinger
  • Pyrazinedicarboxylic-acid derivatives as cell proliferation regulators
    Patent number: 6124298
    Abstract: The present invention relates to novel pyrazine compounds and their use in the regulation of haematopoiesis, in particular in the stimulation of haematopoiesis, and in the treatment of bacterial, viral and fungal diseases.
    Type: Grant
    Filed: August 20, 1999
    Date of Patent: September 26, 2000
    Assignee: Nycomed Imaging AS
    Inventors: Jessie Sandosham, Johann Hiebl, Hermann Kollmann, Alan Cuthbertson, Peter Fischer, Michael Hartmann, Peter Kremminger, Franz Rovenszky, Mette Husbyn
  • Hemoregulatory compounds
    Patent number: 6114357
    Abstract: Novel compounds of general formula (1), which have hemoregulatory activities and can be used to stimulate haematopoiesis and for the treatment of viral, fungal and bacterial infectious diseases.
    Type: Grant
    Filed: February 9, 1999
    Date of Patent: September 5, 2000
    Assignees: SmithKline Beecham Corporation, Nycomed Austria GmbH
    Inventors: Pradip Kumar Bhatnagar, Dirk Andries Heerding, Michael Hartmann, Johann Hiebl, Peter Kremminger, Franz Rovenszky
  • Hemoregulatory compounds
    Patent number: 6107309
    Abstract: The present invention relates to novel compounds which have hemoregulatory activities and can be used to stimulate hematopoiesis and for the treatment of viral, fungal and bacterial infectious diseases.
    Type: Grant
    Filed: December 4, 1998
    Date of Patent: August 22, 2000
    Assignees: SmithKline Beecham Corporation, Nycomed Austria GmbH
    Inventors: Pradip Kumar Bhatnagar, Dirk Andries Heerding, James Francis Callahan, Johann Hiebl, Michael Hartmann, Peter Kremminger, Franz Rovenszky
  • Hemoregulatory compounds
    Patent number: 6077856
    Abstract: Novel compounds of the general formula (I) which have hemoregulatory activities and can be used to stimulate haematopoiesis and for the treatment of viral, fungal and bacterial infectious diseases ##STR1##
    Type: Grant
    Filed: December 14, 1998
    Date of Patent: June 20, 2000
    Assignees: SmithKline Beecham Corporation, Nycomed Austria GmbH
    Inventors: Pradip Kumar Bhatnagar, Dirk Andries Heerding, Michael Hartmann, Johann Hiebl, Peter Kremminger, Franz Rovenszky
  • Hemoregulatory compounds
    Patent number: 6077855
    Abstract: Novel compounds of the general formula (I) which have hemoregulatory activities and can be used to stimulate haematopoiesis and for the treatment of viral, fungal and bacterial infectious diseases.
    Type: Grant
    Filed: December 4, 1998
    Date of Patent: June 20, 2000
    Assignees: SmithKline Beecham Corporation, Nycomed Austria GmbH
    Inventors: Pradip Kumar Bhatnagar, Michael Hartmann, Johann Hiebl, Peter Kremminger, Franz Rovenszky
  • Hemoregulatory compounds
    Patent number: 6051584
    Abstract: Novel compounds of the general formula (I) which have hemoregulatory activities and can be used to stimulate haematopolesis and for the treatment of viral, fungal and bacterial infectious diseases ##STR1##
    Type: Grant
    Filed: November 23, 1998
    Date of Patent: April 18, 2000
    Assignees: SmithKline Beecham Corporation, Nycomed Austria GmbH
    Inventors: Pradip Kumar Bhatnagar, Michael Hartmann, Johann Hiebl, Peter Kremminger, Franz Rovenszky
  • Hemoregulatory compounds
    Patent number: 6030989
    Abstract: Novel compounds of general formula (I) which have hemoregulatory activities and can be used to stimulate haematopoiesis and for the treatment of viral, fungal and bacterial infectious diseases.
    Type: Grant
    Filed: November 23, 1998
    Date of Patent: February 29, 2000
    Assignee: SmithKline Beecham Corporation
    Inventors: Pradip Kumar Bhatnagar, Michael Hartmann, Johann Hiebl, Peter Kremminger, Franz Rovenszky
  • Derivatives of benzosulphonamides as inhibitors of the enzyme cyclooxygenase II
    Patent number: 6004948
    Abstract: Compounds of the formula (I) in which A is oxygen, sulphur or NH; B is a group of the formula (IIa) or (IIb); and the other variables have the meaning given in claim 1, may be used as inhibitors of the enzyme cyclooxygenase II ##STR1##
    Type: Grant
    Filed: September 3, 1998
    Date of Patent: December 21, 1999
    Assignee: Nycomed Austria GmbH
    Inventors: Heinz Blaschke, Peter Kremminger, Michael Hartmann, Harald Fellier, Jorg Berg, Thomas Christoph, Franz Rovenszky, Dagmar Stimmeder
  • Pyrazine fused to a cyclic peptide
    Patent number: 5972926
    Abstract: The present invention relates to pyrazine fused to a cyclic peptide which is capable of regulating, in particular stimulating, haematopoiesis.
    Type: Grant
    Filed: June 5, 1998
    Date of Patent: October 26, 1999
    Assignee: Nycomed Imaging AS
    Inventors: Jessie Sandosham, Johann Hiebl, Hermann Kollmann, Alan Cuthbertson, Peter Fischer, Michael Hartmann, Peter Kremminger, Franz Rovenszky, Mette Husbyn
  • Single chain peptide compounds having hemoregulatory activity
    Patent number: 5629293
    Abstract: There is disclosed single chain peptide compounds, substituted at a C.alpha.-atom of a non-terminal amino acid by a group--A which is defined in claim 1. The native .alpha.-side chain of the C.alpha. atom bonded group to group --A absent. The peptide derivatives according to the invention are useful for inhibiting cell proliferation, especially myelopoietic and bone marrow cells.
    Type: Grant
    Filed: November 30, 1994
    Date of Patent: May 13, 1997
    Assignee: Nycomed Imaging AS
    Inventors: Kjell Undheim, Peter Kremminger, Michael Hartmann
  • Double chain peptide compounds having hemoregulatory activity
    Patent number: 5610141
    Abstract: Dipeptide compounds are disclosed, the two peptide chains being joined together at a C.alpha.-atom of a non-terminal amino acid by a divalent bridging group --A--. The C.alpha.-atoms joined to group --A-- are located in equivalent positions in each peptide and each lack their native .alpha.-side chain. The bridged dipeptide compounds disclosed have a stimulating activity on cell division, especially for myelopoietic and bone marrow cells.
    Type: Grant
    Filed: November 30, 1994
    Date of Patent: March 11, 1997
    Assignee: Nycomed Imaging AS
    Inventors: Kjell Undheim, Magne Solbakken, Erik Agner, Peter Kremminger, Meinolf Lange